Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response.
- DOI
- 10.1007/s11154-025-09984-3
- Published
- 2025 Dec
- Container
- Reviews in endocrine & metabolic disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11154-025-09984-3,
title = {Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response.},
author = {Argente J and Clément K and Duis J and Farooqi IS and Kühnen P and Miller JL and Roth CL and van den Akker E},
year = {2025},
journal = {Reviews in endocrine \& metabolic disorders},
doi = {10.1007/s11154-025-09984-3},
url = {https://doi.org/10.1007/s11154-025-09984-3}
}RIS
TY - JOUR TI - Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response. AU - Argente J AU - Clément K AU - Duis J AU - Farooqi IS AU - Kühnen P AU - Miller JL AU - Roth CL AU - van den Akker E PY - 2025 JO - Reviews in endocrine & metabolic disorders DO - 10.1007/s11154-025-09984-3 UR - https://doi.org/10.1007/s11154-025-09984-3 ER -
APA
J, A., K, C., J, D., IS, F., P, K., JL, M., CL, R., & E, V. D. A. (2025). Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response.. Reviews in endocrine & metabolic disorders. https://doi.org/10.1007/s11154-025-09984-3
Source records
- pubmed · retrieved 2026-09-26T06:54:25.361Z